Processa Pharmaceuticals ... (PCSA)

NASDAQ: PCSA · Real-Time Price · USD

0.23

-0.02 (-8.04%)

At close: May 02, 2025, 3:59 PM

0.24

3.20%

After-hours: May 02, 2025, 04:59 PM EDT

Processa Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	1.19M	4.71M	6.5M	16.5M	15.42M	691.54K	1.74M	2.85M	3.24K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.02M
Long-Term Investments	n/a	n/a	n/a	-2.15M	-1.9M	-1.12M	1.8M	n/a	n/a
Other Long-Term Assets	1.2M	5.54K	5.54K	5.54K	5.54K	5.54K	-2.53M	5.54K	5.53K
Receivables	n/a	n/a	n/a	70.27K	231.75K	n/a	21.58K	62.71K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	682.29K	926.3K	1.88M	n/a	n/a	315.61K	n/a	n/a	n/a
Total Current Assets	1.87M	5.63M	8.39M	18.33M	16.2M	1.01M	2.02M	2.95M	3.24K
Property-Plant & Equipment	75.69K	148.61K	227.59K	74.18K	159.04K	228K	17.38K	25.82K	22.39K
Goodwill & Intangibles	n/a	n/a	n/a	8.06M	8.85M	9.64M	10.44M	n/a	n/a
Total Long-Term Assets	1.27M	154.15K	233.12K	8.14M	9.01M	9.88M	10.46M	31.36K	27.93K
Total Assets	3.23M	5.79M	8.62M	26.46M	25.21M	10.88M	13.21M	2.98M	3.24K
Account Payables	880.88K	311.62K	327.55K	218.91K	320.69K	75.61K	292.1K	50.69K	166.16K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	483.91K
Short-Term Debt	73.02K	n/a	78.9K	71.08K	117.57K	802.5K	230K	2.45M	1.61M
Other Current Liabilities	578.73K	189.04K	110.16K	330.69K	469.86K	316.00	n/a	436.00	n/a
Total Current Liabilities	1.53M	730.58K	998.56K	971.02K	1.22M	1.19M	645.7K	2.6M	2.35M
Long-Term Debt	n/a	n/a	n/a	n/a	44.88K	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	400K	n/a	n/a	9.96K	n/a
Total Long-Term Liabilities	487.00	66.91K	150.55K	7.38K	1.05M	1.68M	2.87M	9.96K	n/a
Total Liabilities	1.53M	797.48K	1.15M	978.4K	2.27M	2.87M	3.51M	2.61M	2.35M
Total Debt	73.51K	150.55K	229.45K	78.46K	328.12K	1.03M	230K	2.45M	1.61M
Common Stock	371.00	129.00	1.61K	1.57K	1.42K	549.00	3.87K	3.53K	1.1K
Retained Earnings	-87.22M	-75.37M	-64.25M	-36.82M	-25.4M	-10.98M	-7.62M	-3.86M	-15.25M
Comprehensive Income	n/a	-0.00	0.00	0.00	n/a	0.00	-1.8M	-3.25K	-19.15K
Shareholders Equity	1.7M	4.99M	7.47M	25.49M	22.94M	8.01M	9.7M	373.16K	-2.35M
Total Investments	n/a	n/a	n/a	-2.15M	-1.9M	-1.12M	1.8M	n/a	1.02M